Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
about
Prostate cancer relevant antigens and enzymes for targeted drug deliveryCD24+/CD38- as new prognostic marker for non-small cell lung cancer.Identification of genes regulating migration and invasion using a new model of metastatic prostate cancerStochastic sensing of Angiotensin II with lysenin channelsPolymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese.Nuclear Ep-ICD expression is a predictor of poor prognosis in "low risk" prostate adenocarcinomasAdoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAMCalcium Influx of Mast Cells Is Inhibited by Aptamers Targeting the First Extracellular Domain of Orai1.Metabolic stress induces a Wnt-dependent cancer stem cell-like state transition.By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasisATP1B3 Protein Modulates the Restriction of HIV-1 Production and Nuclear Factor κ Light Chain Enhancer of Activated B Cells (NF-κB) Activation by BST-2.Circulating tumour cells-monitoring treatment response in prostate cancer.Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins.Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.Epithelial cell adhesion molecule is overexpressed in hypopharyngeal carcinoma and suppresses the metastasis and proliferation of the disease when downregulated.Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.Fingerprinting of Peptides with a Large Channel of Bacteriophage Phi29 DNA Packaging Motor.PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy.Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture.Clinicopathology of EpCAM and EGFR in Human Epithelial Ovarian Carcinoma.Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factorsEpithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
P2860
Q27013843-E78CD02A-B2C2-4E4B-985C-EDA62D403A8EQ30446381-42D07D5D-42B6-41B1-AC2D-5B21CA8A273AQ33714753-D194A231-3856-49B2-90B9-C610734E6C2AQ33732792-CA3684E2-3E0E-4C4D-98F1-A9E3DCFA4215Q35051751-9C0CEBA9-AE29-41A8-BE13-8A1E73B30E8EQ35103343-998B5222-D849-4C56-99F4-A083CED0D928Q35552124-3394B265-B09D-428C-9C24-BD191A3C8C92Q36070773-5F201402-8E9B-42B8-9235-F12C6BD59E49Q36293834-6C55BA82-8815-44BC-9CE1-EFD0E137DC38Q36413730-BD931CC3-CCC3-4D19-AB3B-295EE7677C37Q36744586-A2A62713-26E7-4A08-9456-A59A66394BC0Q38211361-2C448073-3443-4475-A61D-5D007131C01CQ38777639-63442F5C-5076-4B46-AD9F-09C9C66E2DC2Q38958021-E878A722-D0DB-460F-981E-9F0207D7C4E9Q38981795-72B88D78-9693-41D4-A0FD-A58044807C6FQ39070920-0D630BF1-B0A4-4CEC-A24B-59C18E7C7B9FQ39309977-3FA5B2AA-BAC6-4B57-8AE7-E60A633C8274Q39357182-BEFD2EFA-82FF-4755-822F-840D51E1D151Q41241610-EB93A22C-CCEB-421E-82A4-A2D7EE5C7DCBQ51062789-4310E3E5-9E6C-4F17-962B-050C82E42FC3Q57081259-E62CDE46-92C5-446D-A3B0-490210D47C0BQ59136173-8E11CFD7-B000-4A00-A344-D477CC82AB6D
P2860
Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
@en
type
label
Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
@en
prefLabel
Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
@en
P2093
P2860
P1476
Role of the EpCAM (CD326) in prostate cancer metastasis and progression
@en
P2093
Kearsley H John
Paul J Cozzi
Peter H Graham
Sarah Shigdar
P2860
P2888
P304
P356
10.1007/S10555-012-9389-1
P50
P577
2012-12-01T00:00:00Z
P5875
P6179
1016278902